Wednesday’s analyst calls: Carvana gets an upgrade, Goldman sees Tesla decline
How much upside did Barclays predict for Eli Lilly?
Barclays analyst Carter Gould maintained an overweight rating on Eli Lilly and raised the price target by $112 to $1,025, implying a potential increase of roughly 9.9% for the stock. Gould is bullish on Eli Lilly ahead of its quarterly results due on August 8, expecting the company to beat analysts' high consensus expectations.
What new price target did Goldman Sachs set for Tesla?
Goldman Sachs raised its price target on Tesla to $248 from $175. This increase came after Tesla reported better-than-expected deliveries for the second quarter. However, the new forecast still implies a downside of 5% from Tuesday's close. Analyst Mark Delaney maintained a neutral rating on Tesla, stating that while the company is well positioned for long-term growth, weaker market conditions may affect earnings in the near to intermediate term.
What is Bernstein's price target for IREN?
Bernstein's price target for Iris Energy (IREN) is $26, which indicates a potential upside of 102.81% from the stock's current price. They have initiated coverage of IREN with an "outperform" rating, suggesting a positive outlook for the stock3.